Publications by authors named "Hongbei Xu"

Claim this Profile
R
RAGE: a potential target for Epimedium's anti-neuroinflammation role in vascular dementia-insights from network pharmacology and molecular simulation.
Ping Yuan, Wei Chen, Xiaohu Wang, Liangqian Li, Zijun Peng, Hongbei Xu

J Biomol Struct Dyn· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAGE acted as a new anti-inflammatory target for Icariin's treatment against vascular dementia based on network pharmacology-directed verification.
Xiaohu Wang, Wei Chen, Ping Yuan, Hongbei Xu

J Biomol Struct Dyn· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain structures as potential mediators of the causal effect of COVID 19 on migraine risk.
Hongbei Xu, Wei Chen, Yaxin Ju, Hongqun Chen, Ping Yuan

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease as a causal risk factor for diabetic retinopathy: a Mendelian randomization study.
Fu Ouyang, Ping Yuan, Yaxin Ju, Wei Chen, Zijun Peng, Hongbei Xu

Front Endocrinol (Lausanne)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between epilepsy and COVID-19: analysis based on Mendelian randomization and FUMA.
Mingyao You, Ping Yuan, Liangqian Li, Baoduo Li, Zijun Peng, Hongbei Xu

Front Neurosci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIF-1 signalling pathway was identified as a potential new pathway for Icariin's treatment against Alzheimer's disease based on preclinical evidence and bioinformatics.
Mingyao You, Ping Yuan, Liangqian Li, Hongbei Xu

Front Pharmacol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyotrophic lateral sclerosis with primary progressive aphasia: a case report and literature review.
Anni Zhang, Hongbei Xu, Jing Huang, Shipeng Guo, Tian Tian

Neuro Endocrinol Lett· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexisting amyotrophic lateral sclerosis and chorea: A case report and literature review.
Anni Zhang, Hongbei Xu, Jing Huang, Huilan Gong, Shipeng Guo

Medicine (Baltimore)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Mechanism of Epimedium Extract against Ischemic Stroke Based on Network Pharmacology and Experimental Validation.
Hongbei Xu, Mingyao You, Xiang Xiang, Jun Zhao, Ping Yuan

Oxid Med Cell Longev· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OTULIN is a new target of EA treatment in the alleviation of brain injury and glial cell activation via suppression of the NF-κB signalling pathway in acute ischaemic stroke rats.
Hongbei Xu, You Wang, Yong Luo

Mol Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microglia TREM2 is required for electroacupuncture to attenuate neuroinflammation in focal cerebral ischemia/reperfusion rats.
Hongbei Xu, Song Mu, Wenyi Qin

Biochem Biophys Res Commun· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lentivirus-mediated overexpression of OTULIN ameliorates microglia activation and neuroinflammation by depressing the activation of the NF-κB signaling pathway in cerebral ischemia/reperfusion rats.
Hongbei Xu, Wenyi Qin, Xiao Hu, Song Mu, Jun Zhu

J Neuroinflammation· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis